Neurofilament light chain level in cerebrospinal fluid can differentiate Parkinson's disease from atypical parkinsonism: Evidence from a meta-analysis

Journal of the Neurological Sciences

Volumn 352, Issue 1-2, 2015, Pages 84-87

  Sako, Wataru ^a   Murakami, Nagahisa ^a   Izumi, Yuishin ^a   Kaji, Ryuji ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Cerebrospinal fluid; Meta analysis; Multiple system atrophy; Neurofilament light chain; Parkinson's disease; Progressive supranuclear palsy

Indexed keywords

NEUROFILAMENT LIGHT CHAIN; NEUROFILAMENT PROTEIN; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

ARTICLE; CEREBROSPINAL FLUID; HUMAN; META ANALYSIS; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PROTEIN CEREBROSPINAL FLUID LEVEL; SHY DRAGER SYNDROME; DIFFERENTIAL DIAGNOSIS; PARKINSONIAN DISORDERS;

BIOMARKERS; DIAGNOSIS, DIFFERENTIAL; HUMANS; MULTIPLE SYSTEM ATROPHY; NEUROFILAMENT PROTEINS; PARKINSON DISEASE; PARKINSONIAN DISORDERS; SUPRANUCLEAR PALSY, PROGRESSIVE;

EID: 84928368241     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2015.03.041     Document Type: Article

References (22)

1. D.W. Dickson Parkinson's disease and parkinsonism: neuropathology Cold Spring Harb Perspect Med 2 2012 a009258
2. A. Schrag, Y. Ben-Shlomo, and N.P. Quinn Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study Lancet 354 1999 1771 1775
3. A.J. Hughes, Y. Ben-Shlomo, and S.E. Daniel et al. What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathological study Neurology 57 2001 S34 S38
4. A.J. Hughes, S.E. Daniel, and Y. Ben-Shlomo et al. The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service Brain 125 2002 861 870
5. B. Holmberg, B. Johnels, and P. Ingvarsson et al. CSF-neurofilament and levodopa tests combined with discriminant analysis may contribute to the differential diagnosis of Parkinsonian syndromes Parkinsonism Relat Disord 8 2001 23 31
6. W.F. Abdo, B.R. Bloem, and W.J. Van Geel et al. CSF neurofilament light chain and tau differentiate multiple system atrophy from Parkinson's disease Neurobiol Aging 28 2007 742 747
7. R. Constantinescu, L. Rosengren, and B. Johnels et al. Consecutive analysis of cerebrospinal fluid axonal and glial markers in Parkinson's disease and atypical Parkinsonian disorders Parkinsonism Relat Disord 16 2010 142 145
8. S. Hall, A. Ohrfelt, and R. Constantinescu et al. Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and/or parkinsonian disorders Arch Neurol 69 2012 1445 1452
9. C.J. Cochrane, and K.P. Ebmeier Diffusion tensor imaging in parkinsonian syndromes: a systematic review and meta-analysis Neurology 80 2013 857 864
10. W. Sako, N. Murakami, and Y. Izumi et al. MRI can detect nigral volume loss in patients with Parkinson's disease: evidence from a meta-analysis J Parkinsons Dis 4 2014 405 411
11. W. Sako, N. Murakami, and Y. Izumi et al. The difference in putamen volume between MSA and PD: evidence from a meta-analysis Parkinsonism Relat Disord 20 2014 873 877
12. D.J. Gelb, E. Oliver, and S. Gilman Diagnostic criteria for Parkinson's disease Arch Neurol 56 1999 33 39
13. N. Quinn Multiple system atrophy - the nature of the beast J Neurol Neurosurg Psychiatry 1989 78 89 (Special Supplemen)
14. S. Gilman, G.K. Wenning, and P.A. Low et al. Second consensus statement on the diagnosis of multiple system atrophy Neurology 71 2008 670 676
15. I. Litvan, Y. Agid, and D. Calne et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP International Workshop Neurology 47 1996 1 9
16. M. Egger, G.D. Smith, and M. Schneider et al. Bias in meta-analysis detected by a simple, graphical test BMJ 315 1997 629 634
17. C.S. Scherling, T. Hall, and F. Berisha et al. Cerebrospinal fluid neurofilament concentration reflects disease severity in frontotemporal degeneration Ann Neurol 75 2014 116 126
18. R. Constantisnescu, and S. Mondello Cerebrospinal fluid biomarker candidates for parkinsonian disorders Front Neurol 3 2013 187
19. W. Sako, N. Murakami, and Y. Izumi et al. Reduced alpha-synuclein in cerebrospinal fluid in synucleinopathies: evidence from a meta-analysis Mov Disord 29 2014 1599 1605
20. A. Quattrone, G. Nicoletti, and D. Messina et al. MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy Radiology 246 2008 214 221
21. C.C. Tang, K.L. Poston, and T. Eckert et al. Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysis Lancet Neurol 9 2010 149 158
22. S.R. Nair, L.K. Tan, and N.M. Ramli et al. A decision tree for differentiating multiple system atrophy from Parkinson's disease using 3-T MR imaging Eur Radiol 23 2013 1459 1466